At what enterprise value was EUGIN GROUP acquired in 2020?

During the acquisition of EUGIN GROUP by FRESENIUS in 2020, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR.

What was the EV/EBITDA of EUGIN GROUP when it was acquired by FRESENIUS?

The estimated EV/EBITDA multiple for EUGIN GROUP is in the range of 10x - 18x.

When was EUGIN GROUP acquired by FRESENIUS?

EUGIN GROUP was acquired by FRESENIUS in 2020.

What was the EBITDA of EUGIN GROUP during the acquisition?

EUGIN GROUP's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the EUGIN GROUP acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the EUGIN GROUP deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.fresenius.com/node/5159

← DATABASE

Home Database Healthcare & PharmaEUGIN GROUP

12/2020

EUGIN GROUP acquired by FRESENIUS

SPAIN Health Providers / Outpatient Care EV 300M - 700M EUR

Context

Fresenius Helios, the hospital and healthcare services division of Fresenius SE & Co. KGaA, acquired Eugin Group from NMC Health, a UAE-based listed healthcare group, through a dual acquisition structure targeting both the global ex-US operations (via Luarmia S.L.) and the US operations (via NMC Eugin US Corporation, holding 70% of Boston IVF). The remaining 30% of Boston IVF continues to be held by its senior physicians. The transaction establishes Fresenius Helios as a leading international fertility services provider and creates a new dedicated business and reporting unit — alongside Helios Germany and Helios Spain — with a mandate to pursue further buy-and-build expansion.

EUGIN GROUP, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Eugin Group is one of the leading international fertility and assisted reproduction groups, headquartered in Spain and operating a network of numerous clinics and sites across 9 countries and 3 continents. Eugin offers a wide spectrum of state-of-the-art fertility treatment services. The group was transformed from a local Spanish player into a global leader within five years through a combination of healthy organic growth and strategic acquisitions, most notably the 2019 acquisition of Boston IVF — one of the leading US fertility clinic chains — creating one of only two fertility groups with a truly global footprint.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
03/2021	EQT PARTNERS	CERBA HEALTHCARE	FRANCE	Labs (Biology)
02/2021	SILVER LAKE / NESTLE	IVC EVIDENSIA	UNITED KINGDOM	Vet Clinics
12/2020	MEDIAN KLINIKEN	PRIORY GROUP	UNITED KINGDOM	Clinics / Hospitals
12/2020	RADIOLOGY PARTNERS	MEDNAX RADIOLOGY SOLUTIONS	UNITED STATES	Radiology
12/2020	ANTIN INFRASTRUCTURE	HIPPOCRATES (LAF - LA FARMACIA)	ITALY	Pharmacy
11/2020	DWS GROUP	MEDIPASS	ITALY	Radiology
11/2020	L CATTERTON	ALLIANCE ANIMAL HEALTH	UNITED STATES	Vet Clinics
11/2020	ARDIAN	INOVIE GROUP	FRANCE	Labs (Biology)
11/2020	APHEON (EX ERGON)	VIDACURA	GERMANY	Nursing Homes
11/2020	MEDICA GROUP	GLOBAL DIAGNOSTICS	IRELAND	Radiology

REFERENCES

Valuation range: EV 300M - 700M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of EUGIN GROUP by FRESENIUS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: fresenius